Advanced Oncotherapy Share Forecast, Price & News

Advanced Oncotherapy (LON:AVO) Frequently Asked Questions

What stocks does MarketBeat like better than Advanced Oncotherapy?

Wall Street analysts have given Advanced Oncotherapy a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Advanced Oncotherapy wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Advanced Oncotherapy's earnings last quarter?

Advanced Oncotherapy plc (LON:AVO) posted its quarterly earnings results on Monday, June, 29th. The company reported ($9.83) earnings per share for the quarter, missing the Zacks' consensus estimate of ($8.90) by $0.93.
View Advanced Oncotherapy's earnings history.

How has Advanced Oncotherapy's stock been impacted by COVID-19 (Coronavirus)?

Advanced Oncotherapy's stock was trading at GBX 32.50 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, AVO shares have increased by 16.1% and is now trading at GBX 37.75.
View which stocks have been most impacted by COVID-19.

Who are Advanced Oncotherapy's key executives?

Advanced Oncotherapy's management team includes the following people:

• Dr. Michael Jeffrey Sinclair, Exec. Chairman (Age 78, Pay $554.93k)
• Mr. Nicolas Serandour, CEO & Exec. Director
• Prof. Stephen Myers, Exec. Director (Age 74, Pay $255.69k)
• Mr. Ed Lee, COO & Pres of Europe
• Mr. Graham Pughe, Sr. Vice-Pres of Accounting
• Dr. Manuel Gallas, Director of Technical & Engineering
• Mr. David Navas, VP of Investor and PR
• Ms. Bridget Biggar, Director of HR
• Ms. Donatella Ungaro, Managing Director of ADAM
• Ms. Marina Giunta, Head of Physics Group

Who are some of Advanced Oncotherapy's key competitors?

Some companies that are related to Advanced Oncotherapy include Avacta Group (AVCT), Creo Medical (CREO), Viemed Healthcare (VMD), Hamilton Thorne (HTL), Protech Home Medical (PTQ), Titan Medical (TMD), Medica Group (MGP), Viemed Healthcare (VMD), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), MRI Interventions (MRIC), Kromek Group (KMK), Protech Home Medical (PHM), Helius Medical Technologies (HSM) and Intelligent Ultrasound Group (IUG).
View all of AVO's competitors.

What other stocks do shareholders of Advanced Oncotherapy own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Advanced Oncotherapy investors own include UK Oil & Gas (UKOG), Avesoro Resources (ASO), Oxford Biomedica (OXB), BMR Group (BMR), GW Pharmaceuticals (GWPH), Lancashire (LRE), Sirius Minerals (SXX), Renishaw (RSW), Scancell (SCLP) and Tullow Oil (TLW).

What is Advanced Oncotherapy's stock symbol?

Advanced Oncotherapy trades on the London Stock Exchange (LON) under the ticker symbol "AVO."

How do I buy shares of Advanced Oncotherapy?

Shares of AVO and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Advanced Oncotherapy's stock price today?

One share of AVO stock can currently be purchased for approximately GBX 37.75.

How much money does Advanced Oncotherapy make?

Advanced Oncotherapy has a market capitalization of £165.89 million.

How many employees does Advanced Oncotherapy have?

Advanced Oncotherapy employs 2,500 workers across the globe.

What is Advanced Oncotherapy's official website?

The official website for Advanced Oncotherapy is www.advancedoncotherapy.com.

Where are Advanced Oncotherapy's headquarters?

Advanced Oncotherapy is headquartered at Third Fl Clearwater HSE, 4-7 Manchester Street, LONDON, W1U 3AE, United Kingdom.

How can I contact Advanced Oncotherapy?

Advanced Oncotherapy's mailing address is Third Fl Clearwater HSE, 4-7 Manchester Street, LONDON, W1U 3AE, United Kingdom. The company can be reached via phone at +44-20-36178728.